Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Hsiang-Ning Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan. Hauptthemen laut MEDLINE: Achilles Tendon, Actins, Lidocaine, Tenocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, Linkou, Taiwan, Chang Gung Memorial Hospital, Linkou.
Abstract (Originalsprache)
Lidocaine is the most frequently applied local infiltration anesthetic agent for treating tendinopathies. However, studies have discovered lidocaine to negatively affect tendon healing. In the current study, the molecular mechanisms and effects of lidocaine on tenocyte migration were evaluated. We treated tenocytes intrinsic to the Achilles tendons of Sprague–Dawley rats with lidocaine. The migration ability of cells was analyzed using electric cell‐substrate impedance sensing (ECIS) and scratch wound assay. We then used a microscope to evaluate the cell spread. We assessed filamentous actin (F‐actin) cytoskeleton formation through immunofluorescence staining. In addition, we used Western blot analysis to analyze the expression of phospho‐focal adhesion kinase (FAK), FAK, phospho‐paxillin, paxillin, and F‐actin. We discovered that lidocaine had an inhibitory effect on the migration of tenocytes in the scratch wound assay and on the ECIS chip. Lidocaine treatment suppressed cell spreading and changed the cell morphology and F‐actin distribution. Lidocaine reduced F‐actin formation in the tenocyte during cell spreading; furthermore, it inhibited phospho‐FAK, F‐actin, and phospho‐paxillin expression in the tenocytes. Our study revealed that lidocaine inhibits the spread and migration of tenocytes. The molecular mechanism potentially underlying this effect is downregulation of F‐actin, phospho‐FAK, and phospho‐paxillin expression when cells are treated with lidocaine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Taoyuan, Taoyuan City, Taiwan.
- Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan City, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Keelung, Keelung City, Taiwan.
- School of Medicine, Chang Gung University, Taoyuan City, Taiwan.
- Center of Comprehensive Sports Medicine, Chang Gung Memorial Hospital at Taoyuan, Taoyuan City, Taiwan.
ORCID-Profile: Tung-Yang Yu, Chih-Chin Hsu, Li-Ping Lin
Förderung
- Chang Gung Memorial Hospital, Linkou, Taiwan
- Chang Gung Memorial Hospital, Linkou
Zitieren
APA
Chang, H. N., Chen, C. K., Yu, T. Y., Pang, J. S., Hsu, C. C., Lin, L. P., & Tsai, W. C. (2024). Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25762
Vancouver
Chang HN, Chen CK, Yu TY, Pang JS, Hsu CC, Lin LP, et al. Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25762
BibTeX
@article{Chang2024,
author = {Chang, Hsiang-Ning and Chen, Chih-Kuang and Yu, Tung-Yang and Pang, Jong-Hwei S and Hsu, Chih-Chin and Lin, Li-Ping and Tsai, Wen-Chung},
title = {Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25762}
}
EUVIMED